Kyung Nam Pharm Co.,Ltd. (KOSDAQ: 053950)

Kyung Nam Pharm Co.,Ltd. Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	25,978	25,960	42,992	22,931	22,728	23,937
Short-Term Investments	-0	0	500	0	-	-
Trading Asset Securities	7,582	9,053	1,985	316.23	4,766	-
Cash & Short-Term Investments	33,560	35,013	45,478	23,248	27,495	23,937
Cash Growth	-12.44%	-23.01%	95.62%	-15.45%	14.86%	184.37%
Accounts Receivable	13,835	18,321	13,753	16,063	19,536	14,771
Other Receivables	61.97	602.48	116.91	337.14	82.16	71.4
Receivables	13,897	19,314	13,870	16,451	19,670	14,845
Inventory	11,402	13,478	12,611	13,979	9,664	9,601
Prepaid Expenses	249.98	508.29	1,050	976.54	157	3,020
Other Current Assets	456.42	985.2	1,729	265.91	653.05	702.72
Total Current Assets	59,565	69,298	74,738	54,920	57,639	52,105
Property, Plant & Equipment	33,003	46,710	31,235	33,852	32,227	15,827
Long-Term Investments	8,899	5,426	-	-	-	-
Goodwill	-	4,190	-	139.69	139.69	-
Other Intangible Assets	401.67	5,454	804.76	924.01	620.12	159
Long-Term Accounts Receivable	-0	0	-0	-0	0	-
Long-Term Deferred Tax Assets	629.1	881.21	1,922	7,530	7,678	5,590
Other Long-Term Assets	41,243	34,650	29,568	27,940	28,352	739.49
Total Assets	143,741	166,609	138,269	125,307	126,655	74,460
Accounts Payable	4,416	7,242	3,366	4,430	6,341	4,875
Accrued Expenses	585.98	1,134	532.96	566.29	805.93	1,769
Short-Term Debt	9,487	17,497	8,776	11,415	11,618	-
Current Portion of Long-Term Debt	24,182	24,185	24,000	1,800	1,800	-
Current Portion of Leases	151.04	563.48	220.1	342.5	296.41	652.14
Current Income Taxes Payable	-	56.76	0.86	0.77	-	-
Current Unearned Revenue	44.25	215.02	-	-	-	-
Other Current Liabilities	5,314	16,039	7,051	6,857	17,744	3,380
Total Current Liabilities	44,180	66,933	43,947	25,411	38,605	10,676
Long-Term Debt	6,613	8,760	-	25,650	27,450	-
Long-Term Leases	83.46	324.7	197.08	308.13	228.1	390.49
Other Long-Term Liabilities	344.97	759.43	354.33	592.33	836.36	165.68
Total Liabilities	52,227	76,777	44,498	52,778	69,291	13,266
Common Stock	3,559	17,797	16,740	10,025	8,721	8,527
Additional Paid-In Capital	119,477	104,275	98,061	72,237	56,009	54,207
Retained Earnings	-34,014	-45,041	-23,102	-11,506	-9,173	-3,392
Treasury Stock	-1.08	-1.08	-1.08	-1.08	-1.08	-1.08
Comprehensive Income & Other	2,492	2,332	2,074	1,774	1,807	1,853
Total Common Equity	91,514	79,362	93,771	72,529	57,364	61,194
Minority Interest	-	10,471	-	-	-	-
Shareholders' Equity	91,514	89,832	93,771	72,529	57,364	61,194
Total Liabilities & Equity	143,741	166,609	138,269	125,307	126,655	74,460
Total Debt	40,517	51,330	33,193	39,515	41,392	1,043
Net Cash (Debt)	-6,957	-16,318	12,285	-16,268	-13,898	22,895
Net Cash Per Share	-195.56	-460.29	421.03	-712.04	-805.76	1474.27
Filing Date Shares Outstanding	35.59	35.59	33.48	20.05	17.44	17.05
Total Common Shares Outstanding	35.59	35.59	33.48	20.05	17.44	17.05
Working Capital	15,385	2,365	30,792	29,509	19,035	41,429
Book Value Per Share	2571.12	2229.69	2800.84	3617.53	3288.78	3588.41
Tangible Book Value	91,112	69,717	92,966	71,465	56,604	61,035
Tangible Book Value Per Share	2559.83	1958.73	2776.81	3564.48	3245.22	3579.09
Land	-	27,988	17,715	15,707	15,707	3,893
Buildings	-	13,013	10,979	9,860	9,754	6,395
Machinery	-	13,168	10,648	10,553	7,733	6,889
Construction In Progress	-	888.2	164.4	4,974	6,379	4,916

Source: S&P Capital IQ. Standard template. Financial Sources.